Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

342 results about "Cellular engineering" patented technology

Cellular engineering, principally the control and regulation of cell proliferation, differentiation, and function, is vital to the success of cell-based therapeutic applications and technologies.

Non-viral cell engineering

PCT designated stage expiredWO2024259376A3Immunoglobulin superfamilyStable introduction of DNAVirusGene
Provided herein are compositions and methods for improving non-viral insertion of genes into safe harbor loci of cells such as immune cells.
Owner:ARSENAL BIOSCIENCES INC

Stomach signet ring cell carcinoma tissue preserving fluid, digestive juice and special culture system of organoid

PendingCN118923665Aincrease success ratedelayed digestionCell dissociation methodsGastrointestinal cellsSignet ring cell carcinomaDigestants
The invention relates to the technical field of cell engineering, in particular to a gastric signet ring cell carcinoma tissue preserving fluid, digestive juice and a special culture system of organoids. The method disclosed by the invention relates to the whole process from elm to culture of a gastric signet-ring cell carcinoma specimen, and specifically designs a gastric signet-ring cell carcinoma tissue transport preserving fluid, a tissue digestive juice and an organoid complete culture medium based on the characteristics of gastric signet-ring cell carcinoma tissue. The whole culture system has high specificity and higher success rate for the primary culture of the organoids derived from the gastric signet ring cell carcinoma.
Owner:THE FIRST HOSPITAL OF CHINA MEDICIAL UNIV

Multiplexed retron genome editing in prokaryotic and eukaryotic genomes

PCT designated stage expiredWO2025007020A1HydrolasesTransferasesGenome editingRetroposon
Provided herein are compositions and methods for modification of the retron editing system to enable multiple simultaneous edits in prokaryotic and / or eukaryotic cells. Such compositions and methods find use in, for example, therapeutic editing and cell engineering, such as for bioproduction.
Owner:THE J DAVID GLADSTONE INSTITUTES +3

Using Machine Learning to Predict Cell Therapy Characteristics

Disclosed are systems and methods for improving processes for developing cell therapies by applying machine learning to data including manufacturing process data and clinical measurements (e.g., patient response and treatment data) to determine parameters and settings for a manufacturing process for engineering cells for use in cell therapy. Parameters and settings for a manufacturing process for genetically engineered T-cells including, but not limited to, Chimeric Antigen Receptor (CAR) T cells can be determined. A method can include receiving a set of process parameters of a cell engineering process, predicting a clinical response associated with an output of the cell engineering process by applying a machine learning model on the received set of process parameters, where the machine learning model is trained on process parameter data and clinical response data, and generating a visualization for use in a graphical user interface of the predicted clinical response.
Owner:AICELLA INC

Application of Wnt2 gene in buffalo ovarian granular cells

PendingCN119592628Apromote proliferationHigh expressionGenetically modified cellsNucleic acid vectorSignaling Pathway GeneGranular cell
The invention discloses application of a Wnt2 gene in buffalo ovarian granular cells, and belongs to the technical field of cell engineering and gene engineering. Wnt2 is taken as a research object, the Wnt2 overexpression vector or Wnt2 siRNA is transfected to the ovarian granulosa cells respectively by constructing the Wnt2 overexpression vector and synthesizing small interfering RNA (Wnt2 siRNA), then changes of signal channel gene mRNA and protein level related to ovarian granulosa cell apoptosis, proliferation and E2 and P4 secretion are detected, and finally phenotypic changes of the ovarian granulosa cells are detected. Results show that Wnt2 can inhibit apoptosis of ovarian granular cells and promote proliferation and E2 and P4 secretion. By exploring the application of the Wnt2 in the ovarian granular cells, the application has good application in researching an ovarian follicle atresia mechanism, initial estrus initiation and the like.
Owner:GUANGXI ZHUANG AUTONOMOUS REGION BUFFALO INST

Organ-like model for simulating tumors with different matrix rigidities in body

The invention belongs to the crossing field of cell engineering and biotechnology, and provides an organoid model for simulating tumors with different matrix rigidities in vivo, the model is composed of sodium alginate polysaccharide and matrigel in different proportions and organoid embedded in the sodium alginate polysaccharide and matrigel, and matrixes outside the organoid have different matrix rigidities; the preparation method has the greatest advantage that the tumor organs with different matrix rigidities can be prepared only by adjusting the concentration of the sodium alginate polysaccharide; the invention provides a reasonable, simple and easy-to-obtain organ-like model with high repeatability for fundamental research on tumors with different matrix rigidities clinically, screening of drugs for inhibiting tumor proliferation, adhesion and metastasis, research on drug resistance of tumor cells and the like.
Owner:FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV

Non-viral cell engineering

PCT designated stage expiredWO2024259376A2Immunoglobulin superfamilyStable introduction of DNAVirusGene
Provided herein are compositions and methods for improving non-viral insertion of genes into safe harbor loci of cells such as immune cells.
Owner:ARSENAL BIOSCIENCES INC

Method for enhancing Treg cell function and application

The invention provides a method for enhancing Treg cell functions and application, and belongs to the technical field of cell engineering. According to the method, hUC-MSCs are irradiated by gamma rays to form feeder layer cells, and then the feeder layer cells and Treg cells are co-cultured to obtain the Treg cells with enhanced cell functions. Through the co-culture of the feeder layer cells and the Treg cells, the inhibition ability of the Treg cells on activation and proliferation of immune cells can be enhanced, and the feeder layer cells and the Treg cells can be used as universal cells in clinical researches of autoimmune diseases, graft versus host diseases and the like.
Owner:JINAN WANQUAN BIOTECHNOLOGY CO LTD

Serum-free medium for in-vitro proliferation of poultry muscle stem cells and application of serum-free medium

The invention discloses a serum-free culture medium for in-vitro proliferation of poultry muscle stem cells and application of the serum-free culture medium, and belongs to the technical field of cell engineering, a basic serum-free culture medium is DMEM-F12, a complete serum culture medium is a mixture of DMEM-F12 added with 10% of fetal calf serum and 1% of mycillin, and the volume ratio of a culture medium supplement to the basic culture medium is 1: 1000; the serum-free culture medium contains a supplement; the supplement comprises the following compositions: insulin, transferrin, fibroblast growth factor 2, epidermal growth factor, catalase, ethanolamine, vitamin B12, linoleic acid, linolenic acid, retinol acetate, tocopherol, L-alanine, L-proline, sodium selenite, sodium pyruvate, reduced glutathione, berberine hydrochloride and analogues thereof.
Owner:CHINA MEAT RES CENT

Construction method and application of sika deer immortalized renal epithelial cell line

The invention relates to the technical field of cell engineering, and particularly discloses a construction method and application of a sika deer immortalized renal epithelial cell line, and the construction method comprises the following steps: taking renal epithelial primary cells from healthy sika deer renal cortex tissues to obtain primary renal epithelial cells; treating the primary renal epithelial cells with trypsin to obtain a cell suspension; inoculating the cell suspension into a complete culture medium, and transfecting with lentivirus loaded with SV40 large T antigen genes to obtain transfected cells; 3 [mu] g / mL puromycin is applied to the transfected cells for selective culture, so that non-transfected cells are eliminated, and drug-resistant cells are obtained; carrying out continuous passage on the drug-resistant cells for at least 30 generations to obtain the immortalized renal epithelial cell line of the sika deer; according to the invention, through a specific action mechanism (inhibiting a p53 / pRb pathway and blocking cell cycle exit) of the SV40 large T antigen, a proliferation limit caused by inhibition of telomerase activity of primary cells of the cervidae animals is overcome, and a cell resource library capable of realizing continuous passage is established.
Owner:JILIN AGRICULTURAL UNIV

Application of SFRP1 gene in buffalo ovarian granular cells

PendingCN119639815AHigh expressionavoid latchFermentationVector-based foreign material introductionGranular cellSignaling Pathway Gene
The invention discloses application of an SFRP1 gene in buffalo ovarian granular cells, and belongs to the technical field of cell engineering and gene engineering. According to the invention, SFRP1 is taken as a research object, an SFRP1 overexpression vector or siRNA-SFRP1 is respectively transfected to ovarian granular cells by constructing the SFRP1 overexpression vector and synthesizing small interfering RNA (siRNA-SFRP1), then changes of signal channel gene mRNA and protein level related to ovarian granular cell apoptosis, proliferation and E2 and P4 secretion are detected, and finally phenotypic changes of the ovarian granular cells are detected. Results show that the SFRP1 can inhibit apoptosis of ovarian granular cells and promote proliferation and E2 and P4 secretion. The application of the SFRP1 in the ovarian granular cells is explored, and the SFRP1 has good application in research of an ovarian follicle atresia mechanism, initial estrus initiation and the like.
Owner:GUANGXI ZHUANG AUTONOMOUS REGION BUFFALO INST

Red cell membrane with complete structure as well as preparation method and application of red cell membrane

The invention belongs to the technical field of cell engineering and biochemical detection, and particularly relates to an erythrocyte membrane with a complete structure and a preparation method and application thereof. The red blood cells are split by limiting the components of the release liquid, the conditions are mild, protein components such as hemoglobin in the red blood cells can be released, the cell attributes are removed, the integrity of the internal skeleton structure and the activity of the membrane surface antigen are reserved, the complete structure of the red cell membrane is kept, meanwhile, the key blood group antigen on the surface is reserved, and the effect is good. The problem of antigenicity reduction caused by erythrocyte membrane fragmentation is avoided. After the erythrocytes are lysed, the nanoparticles are coupled to the surface of the erythrocyte membrane, so that the agglutination reaction of the erythrocyte membrane under the induction of the antibody can be visualized. The engineering red blood cell biological membrane is preserved by adopting a fixed program, so that the damage of ice crystals to the engineering red blood cell biological membrane can be effectively avoided, the antigenicity of the membrane is not influenced, the membrane can be preserved for a long time at normal temperature, and the shelf life can be prolonged to two years or more.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Tissue preserving fluid and application thereof in keeping cell viability in tissue

The invention relates to the technical field of cell engineering, in particular to a tissue preserving fluid and application thereof in keeping cell viability in tissues. The invention provides a tissue preservation solution. The tissue preservation solution comprises the following components in volume concentration: 70-90% of fetal calf serum, 5-15% of dimethyl sulfoxide and 0-15% of a DMEM (dulbecco's modified eagle medium) liquid culture medium. The tissue preserving fluid obtained by compounding fetal calf serum and dimethyl sulfoxide according to a proper proportion can be used for establishing primary cells, and the primary cells separated from a preserved tissue sample are high in multiplication capacity and can be subjected to subculture; besides, the tissue preserving fluid provided by the invention is simple in proportioning, can keep the activity of cells in tissues preserved within 30 days, is suitable for separating primary cells from field environment samples, and provides technical support for preserving tissue samples for primary cell culture in different environments.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Application of nano-iron in vascular endothelial cells

The invention discloses application of nano-iron in vascular endothelial cells, and belongs to the technical field of cell engineering and genetic engineering. According to the invention, PEI coated Fe3O4 is taken as a research object, the application of PEI coated Fe3O4 in vascular endothelial cells is researched by adopting a molecular and cell biology method, and regulation of PEI coated Fe3O4 on vascular endothelial regeneration of the vascular endothelial cells after myocardial infarction is verified from multiple levels and multiple angles. The invention can provide a new reference for the recovery of cardiac functions after myocardial infarction, and has good application value.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Kit for cell engineering

The utility model discloses a kit for cell engineering, belongs to the technical field of kits, and particularly relates to a cell sample transport case which comprises a case body, and a supporting plate is arranged on the inner side of the case body; according to the test tube rack, the distance between the first test tube rack and the second test tube rack can be adjusted through the arranged distance adjusting mechanism, test tubes with different heights can be limited, the adjusting plate can adjust the relative positions of the first test tube groove and the second test tube groove through the adjusting screw rod, and when the test tubes are inserted into the first test tube groove and the second test tube groove, the test tubes can be fixed. The adjusting plate is moved, the first test tube groove and the second test tube groove abut against the two sides of a test tube respectively, the test tube can be clamped, shaking of the test tube in the moving process is avoided, and the test tubes of different sizes can be clamped by adjusting the relative positions of the first test tube groove and the second test tube groove. Test tubes with different sizes can be limited and clamped, and the application range of the kit can be effectively widened.
Owner:ENDA CELL GENETIC ENG CO LTD

Modified gamma delta t cells

The technology relates in part to methods for activating and expanding multi-subsets of gamma delta T cells. In some aspects, the technology relates to multi-subsets of gamma delta T cells. In some aspects, the technology relates to activated and expanded multi-subsets of gamma delta T cells produced by methods described herein. In some aspects, the multi-subsets of gamma delta T cells are modified. In some aspects, the multi-subsets of gamma delta T cells comprise one or more chimeric antigen receptors. In some aspects, the chimeric antigen receptors comprise one or more antigen binding domains with binding specificity to TROP2 and / or PD-L1. In some aspects, the multi-subsets of gamma delta T cells express IL-15. In some aspects, the multi-subsets of gamma delta T cells comprise one or more genome modifications. In some aspects, the multi-subsets of gamma delta T cells comprise a TGFβR2 knock-out. The technology also relates in part to single-domain antibodies (nanobodies) that target TROP2, PD-L1, or TROP2 and PD-L1, uses for immune cell engineering, pharmaceutical compositions thereof, diagnostic and non-diagnostic reagents thereof, and therapeutic and non-therapeutic methods of use thereof.
Owner:POINTLOMA BIOSCIENCES INC

Mitochondria-enhanced dental pulp mesenchymal stem cells as well as preparation method and application thereof

The invention is applicable to the technical field of cell engineering, and provides a mitochondria-enhanced dental pulp mesenchymal stem cell and a preparation method and application thereof, and the preparation method comprises the following steps: co-culturing platelet-rich fibrin and dental pulp mesenchymal stem cells by using a Transwell chamber to obtain the mitochondria-enhanced dental pulp mesenchymal stem cell. The platelet-rich fibrin transmits mitochondria to the dental pulp mesenchymal stem cells to improve the regeneration capacity of the dental pulp mesenchymal stem cells. According to the invention, an autologous platelet enrichment, namely platelet-rich fibrin, is used as a mitochondria donor with a respiratory function, mitochondria is continuously transferred to the dental pulp-derived mesenchymal stem cells through a cell bioengineering technology, and the mitochondria-enhanced dental pulp mesenchymal stem cells are constructed and applied to tissue damage repair; the vascular regeneration regulation and control capability of the dental pulp mesenchymal stem cells is obviously improved, and the existing mesenchymal stem cell treatment technology is obviously improved.
Owner:JILIN UNIVERSITY

Quality control methods for automated cell processing

The present disclosure provides methods for assessing and optimizing cellular quality of a cell-based therapy that is being produced in an automated cell engineering system. The methods suitably include monitoring molecular characteristics of the cells before, during, and after the automated process to provide feedback to the process parameters. In embodiments, the cells being produced are Chimeric Antigen Receptor (CAR) T-cells.
Owner:OCTANE BIOTECH INC

Moldable, stretchable, and self-healing hydrogel adhesives

Cell engineering, soft robotics and wearable electronics often desire soft materials that are easy to deform, self-heal, and relax stress. Hydrogel, a type of hydrophilic networks, which can be made responsive to environmental stimuli, are often used in the aforementioned applications. However, conventional hydrogels often suffer from poor stretchability and repairability. Here, we report hydrogels consisting of boronic ester dynamic covalent bonds in a double network of poly(vinyl alcohol) together with chitosan, demonstrating extreme stretchability (up to 310 times of the original length), instant self-healing (within 5 sec), reusability as well as inherent adhesion. Their instant stress relaxation as a result of low activation energy of the boronic ester bond exchange (less than 20 KJ / mol) contributes to the extreme stretchability and self-healing behaviors. The hydrophilic environment readily incorporates various additives and provide opportunities in conductive soft materials, bio-signaling, and soft artificial joint.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Application of CDH1 in promoting cell production and / or exosome release

The invention relates to the field of cell engineering, in particular to application of CDH1 in promoting cell production and / or exosome release. According to the invention, after the lentiviral vector of the over-expressed CDH1 gene is constructed, tumor cells are transfected by the lentiviral vector, and finally the tumor cell strain capable of stably expressing CDH1 is obtained. Through extraction and detection, the cell strain obviously improves the yield of the exosome in unit cell and unit culture medium volume, and the yield of the exosome is obviously improved.
Owner:INST OF HEALTH & MEDICINE HEFEI COMPREHENSIVE NAT SCI CENT

Methods for enhancement of engineered cell therapies in cancer treatment

Methods are provided for reprogramming M2-like macrophages to M1-like macrophages, which reverses the proinflammatory to anti-inflammatory shift observed during the course of certain cancers, co-administered with one or more types of engineered cells such as, without limitation, CAR T-cells, engineered natural killer cells, engineered stem cells or the like. The compounds comprise an immune modulator that targets a pattern recognition receptor of a cell and are specific to the cells of interest through the incorporation of a targeting moiety (e.g., folate or a functional fragment or analog thereof). Releasable and / or non-releasable linkers can be included and engineered to facilitate the optimal delivery of the immune modulator. The compounds and compositions can be employed in one or more methods of treatment for cancers.
Owner:PURDUE RES FOUND

Application of CD40 in promoting cell production and / or exosome release

The invention relates to the field of cell engineering, in particular to application of CD40 in promoting cell production and / or exosome release. According to the invention, after a lentiviral vector overexpressing the CD40 gene is constructed, the lentiviral vector transfects tumor cells, and finally the tumor cell strain stably expressing CD40 is obtained. Through extraction and detection, the cell strain obviously improves the yield of the exosome in unit cell and unit culture medium volume, and the yield of the exosome is obviously improved.
Owner:INST OF HEALTH & MEDICINE HEFEI COMPREHENSIVE NAT SCI CENT

Ginseng cell engineering tumor vaccine as well as preparation method and application thereof

The invention relates to the technical field of biological medicine, and provides a ginseng cell engineering tumor vaccine as well as a preparation method and application thereof. The ginseng cell engineering tumor vaccine comprises an exosome derived from a recombinant ginseng cell capable of expressing a tumor antigen; the recombinant ginseng cell capable of expressing the tumor antigen is obtained by introducing a recombinant plasmid containing tumor antigen DNA into a ginseng cell. According to the invention, ginseng cells in Chinese herbal medicines are taken as host cells for recombinant expression of tumor antigens, large-scale production of tumor vaccines can be realized through construction of an engineering recombinant cell system, biocompatibility and uniformity of the vaccines can be maintained, and safety risks can be reduced. Meanwhile, the prepared tumor antigen recombinant expression ginseng cell exosome can integrate the antigen, an adjuvant and a carrier, and the antigen phagocytosis, maturation and antigen peptide presentation capabilities of APCs are enhanced.
Owner:NANJING UNIV OF TRADITIONAL CHINESE MEDICINE

Preparation method and application of CAR-T cell for overexpressing C1QBP

The invention provides a preparation method and application of CAR-T cells for overexpressing C1QBP, and relates to the field of cell engineering. According to the CAR-T cell overexpressing the C1QBP, the energy metabolism of the cell is optimized by improving the oxidative phosphorylation of mitochondria, the formation of memory-like T cells is promoted, and the anti-tumor activity and long-term durability of the CAR-T cell are enhanced. The cells can survive in a tumor microenvironment for a long time, and the anti-tumor effect of the cells is more durable than that of traditional CAR-T cells. Therefore, a new direction is provided for research and development of cellular immunotherapy.
Owner:ANHUI MEDICAL UNIV

Breast cancer carboplatin drug-resistant cell strain and construction method thereof

The invention relates to the technical field of cell engineering, in particular to a breast cancer carboplatin drug-resistant cell strain and a construction method thereof, the breast cancer carboplatin drug-resistant cell strain is preserved in Guangdong Microbial Culture Collection Center on October 16, 2024, the preservation number is GDMCC No: 6528, and the preservation number is CGMCC NO: 6528. The drug-resistant cell strain MDA-MB-231 / CBP constructed in the invention can stably grow and pass in a carboplatin culture system with an action concentration of 20 [mu] M, has a carboplatin resistance index (RI) of 10.7, provides a basis for research of a carboplatin drug-resistant mechanism and development of related targets, and has a wide application prospect. The invention provides a drug-resistant cell model for researching the drug resistance mechanism of human breast cancer cells to carboplatin, searching an effective treatment method for overcoming human breast cancer drug resistance, preparing antitumor drugs, screening tumor drug resistance reversal drugs, guiding clinical medication and the like, and has important effects and good application prospects.
Owner:GUANGXI MEDICAL UNIVERSITY

Application of Siglec7 in promoting cell generation and / or exosome release

The invention relates to the field of cell engineering, in particular to application of Siglec7 in generation and / or release of exosomes in tumor cells. According to the invention, after a lentiviral vector of an overexpressed Siglec7 gene is constructed, tumor cells are transfected with the lentiviral vector, and finally the tumor cell strain stably expressing Siglec7 is obtained. Through extraction and detection, the cell strain obviously improves the yield of the exosome in unit cell and unit culture medium volume, and the yield of the exosome is obviously improved.
Owner:INST OF HEALTH & MEDICINE HEFEI COMPREHENSIVE NAT SCI CENT

Method for directly inducing organoid from IPS and application

ActiveCN119490950AImprove cryopreservation survival rateGood freezing survival rateArtificial cell constructsArtificially induced pluripotent cellsGerm layerDisease
The invention discloses a method for directly inducing generation of organoids from IPS and application, and belongs to the field of cell engineering. The invention provides a method for directly and rapidly generating a target organ based on human IPS, and the lung organ, the placenta organ and the blood vessel organ are obtained. According to the method, the organoid represented by three germ layers is induced, so that the method is suitable for constructing various organoid. Compared with the prior art, the method has the advantages that step-by-step induction is not needed, one-step construction is successful, the operation is simple, the construction time is greatly shortened, the process is repeatable, long-term stable culture and passage are realized under in-vitro conditions, and the freezing survival rate is high; the method has the advantages that the method is simple in operation, the cultured organoid is good in homogeneity, RNA-seq results show that high expression of the blood vessel related genes appears in the organoid, and the maximum length of the organoid can reach 400 micrometers, so that the culture method can spontaneously induce expression of part of the blood vessel related genes to support growth of the organoid. The invention provides an important tool for researching pathogenesis of diseases and subsequent drug development.
Owner:KUNMING UNIV OF SCI & TECH

Csdc2 overexpression vector and construction method of interference cell model

The invention discloses a construction method of a Csdc2 overexpression vector and an interference cell model, and belongs to the technical field of cell engineering and gene engineering. Csdc2 is found to be an important gene for regulating and controlling periodic development of hair follicles, and gene expression is acted by related hormones and participates in regulation and control of villus growth of down producing goats. The Csdc2 is taken as a research object, the Csdc2 gene is overexpressed through a gene engineering technology, and the Csdc2 in the dermal papilla cell of the down producing goat can be accurately overexpressed; the expression of the goat Csdc2 gene at the mRNA level can be effectively inhibited by acting the siRNA for inhibiting the expression of the goat Csdc2 gene on the dermal papilla cells of the down producing goat, and successful establishment of a Csdc2 overexpression vector and siRNA interference cell model is proved. The Csdc2 gene is helpful for researching the function of the Csdc2 gene, and has a good application value for researching the molecular mechanism of periodic growth of secondary hair follicles of down producing goats and regulating and controlling the growth of villus.
Owner:SHIHEZI UNIVERSITY

Insulin treatment to improve T cell engineering

Provided herein, inter alia, are methods and compositions for engineering T cells. The methods include culturing T cells with insulin during engineering of the T cells. The methods provided herein contemplate to increase cell viability, expansion and gene editing efficiency, allowing for an increase in the total number of engineered T cells.
Owner:GENENTECH INC

Monoclonal antibody 1H1 for resisting H6 subtype avian influenza virus hemagglutinin protein and application of monoclonal antibody 1H1

The invention belongs to the technical field of biology, and relates to an anti-H6 subtype avian influenza virus hemagglutinin protein monoclonal antibody 1H1 and application thereof, cell engineering and antibody engineering technologies are utilized to obtain a hybridoma cell line for secreting a hemagglutinin monoclonal antibody, ascites is induced by mice of the same strain to prepare the anti-hemagglutinin protein monoclonal antibody 1H1, the anti-hemagglutinin protein monoclonal antibody 1H1 is identified as an IgG1, kappa type, and the anti-hemagglutinin protein monoclonal antibody 1H1 is identified as an anti-H6 subtype avian influenza virus hemagglutinin protein monoclonal antibody. And the application of the antibody is realized through technologies of affinity purification, immunization and the like. The monoclonal antibody has the advantages that the preparation method is simple and easy to implement, more importantly, the monoclonal antibody prepared by the method can have multiple purposes, an effective tool is provided for auxiliary diagnosis of H6 subtype avian influenza virus infection in a clinical sample, and the monoclonal antibody can be popularized and applied to multiple detection technologies and clinical and experimental research.
Owner:THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE